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ABSTRACT  The serotonin receptor 5-HT2B has been shown to be critically important during em-
bryogenesis as the knockout of this gene in mice causes heart defects and embryonic lethality 
that impairs further analyses on other embryonic cell and tissue types. In the present review, we 
highlight how the use of Xenopus laevis, an alternative vertebrate model suitable for gene loss 
and gain of function analyses, has contributed to our understanding of the role of 5-HT2B signal-
ing during development. In vivo studies showed that 5-HT2B signaling is not only required for 
heart development, but that it also has a crucial role in ocular and craniofacial morphogenesis, 
being involved in shaping the first branchial arch and the jaw joint, in retinogenesis and possibly 
in periocular mesenchyme development. These findings may be relevant for our understanding 
of congenital defects including human birth malformations. In addition, 5-HT2B appears to be re-
quired for the therapeutic actions of selective serotonin reuptake inhibitors commonly prescribed 
as antidepressant drugs to pregnant and lactating women. We discuss how the understanding of 
the molecular basis of serotonin signaling in a suitable animal embryogenesis model may open 
new lines of investigations and therapies in humans. 
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Serotonin, an ancient molecule with unsuspected and 
still unveiled functions
 Serotonin (5-hydroxytryptamine, 5-HT) is a phylogenetically 
ancient monoamine that fulfills a broad role in the control of many 
vital functions including the control of gastrointestinal motility and 
secretion, cardiovascular regulation, hemostatic processes, the 
regulation of circadian rhythms, the control of the sleep–wake 
cycle, memory and learning, perception of pain, appetite and sexual 
behavior (reviewed by Berger et al., 2009). The broad action of the 
serotonin signaling system has attracted the interest of research-
ers in various fields of biology and molecular medicine, spanning 
from developmental biology, neurobiology to molecular psychiatry.
5-HT is best known for its role in the nervous system where it 
is one of the neurotransmitters mainly involved in the etiology of 
various human psychiatric disorders, including anxiety, depres-
sion, obsessive–compulsive disorders, schizophrenia, pain and 
migraine. Accordingly, many substances that interfere with the 
serotonergic system are commonly used as therapeutic agents. 
Selective serotonin reuptake inhibitors (SSRIs) are, in fact, the 
most frequently prescribed drugs for the treatment of depression 
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and anxiety-related disorders (Berton and Nestler, 2006). These 
drugs inhibit the function of the serotonin transporter (5-HTT) induc-
ing an accumulation of extracellular 5-HT and an increase of the 
magnitude and duration of the activity of 5-HT on 5-HT receptors 
(Shafer et al., 1999). 
In the adult brain 5-HT is synthesized in serotonergic neurons of 
the raphe nuclei that represent one of the most widely distributed 
neuronal systems in the vertebrate brain. In addition, several other 
tissues produce large amount of 5-HT, namely the pineal gland, 
where 5-HT is a precursor of melatonin, the enterochromaffin and 
myenteric cells of the gut and the bone (cf. Tsapakis et al., 2012). 
Collectively, the tissue sources outside the brain produce about 
95% of 5-HT. 
Since the pioneer studies of Buznikov and his collaborators 
(reviewed in Buznikov, 2007) it has becoming clear that 5-HT, 
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in addition to its well defined function as neurotransmitter, par-
ticipates in the regulation of early development in many animal 
phyla before the onset of neurogenesis. 5-HT thus plays a role as 
a morphogen-like signal in development before it acts as a neu-
rotransmitter (Lauder, 1993; Gaspar et al., 2003). 5-HT synthesis 
and uptake become active at early stages during embryogenesis 
where it modulates a number of developmental processes includ-
ing cell proliferation, migration and differentiation (Gaspar et al., 
2003). During mammalian embryogenesis 5-HT is supplied to the 
embryo by the maternal blood (Côté et al., 2007). Moreover, an 
early transient placental source of 5-HT for the fetal circulation 
has been detected both in mice and humans (Bonnin et al., 2011). 
In the central nervous system (CNS) serotonergic neurons are 
among the earliest neurons to be generated and 5-HT is released 
by growing axons before conventional synapses are established. 
In addition to the sites of 5-HT production, there are a number of 
cells that capture and store 5-HT, acting as 5-HT reservoirs during 
development. In mice uptake of 5-HT during early development 
is first observed in non-neural tissues such as the heart, the liver, 
the cranial mesenchyme, the migrating cranial neural crest cells 
(NCCs), dorsal ganglia and retinal ganglion cells (Lauder and 
Zimmerman, 1988; Narboux-Nème et al., 2008). High affinity 
uptake of 5-HT in these structures highlights the involvement of 
5-HT signaling in their development and suggests that 5-HT must 
be finely modulated.
So far evidence has been presented for 5-HT involvement in the 
establishment of left-right asymmetry, the craniofacial, limb, bone 
and heart development, the closure of the neural tube and neu-
ronal differentiation during early neurogenesis (Whitaker-Azmitia, 
2001; Levin et al., 2006; Beyer et al., 2012; Vandenberg et al., 
2013). In mice 5-HT has been found to influence the development 
of the whisker-barrel fields in the somatosensory cortex and the 
thalamocortical axon guidance, suggesting that dysfunction of 
5-HT signaling during development may alter brain circuitry and 
functioning (Cases et al., 1996; Persico et al., 2001; Bonnin et al., 
2007). Recently, the generation of a knockout mouse line lacking 
the tryptophan hydroxylase 2 (Tph2), the brain enzyme for 5-HT 
synthesis, has shown that the lack of 5-HT in the brain produces 
severe abnormalities in the serotonergic circuitry (Migliarini et al., 
2012).
The biological actions of 5-HT are mediated by numerous 
cognate receptors that are grouped into seven classes (5-HT1-7). 
Except for 5-HT3 receptors, which are ligand-gated ion channels, 
all belong to G protein-coupled receptors and among these, the 
5-HT2 receptors class seems to be particularly important in me-
diating the effects of 5-HT on embryonic development. Blockade 
of serotonergic signaling by the pan-5-HT2 receptor antagonist 
ritanserin perturbs development of the heart, the face and eyes both 
in mice and Xenopus, suggesting a conservation of this signaling 
pathway across vertebrate evolution (Choi et al., 1997; Bhasin et 
al., 2004; De Lucchini et al., 2005). The 5-HT2B receptor has been 
shown to be an important regulator of the mouse cardiac morpho-
genesis since its genetic ablation leads to mouse embryonic and 
postnatal lethality due to abnormal heart development (Nebigil et 
al., 2000; Nebigil et al., 2001). 5-HT2B knockout increases impul-
sive behaviors in mice and a human population-specific 5-HT2B 
stop codon was found to be associated with psychiatric diseases 
marked by impulsivity (Bevilacqua et al., 2010). 5-HT2B receptor 
is also present on embryonic raphe neurons and takes part in 
the control of 5-HTT functions in differentiating serotonergic cells 
(Launay et al., 2006). Recently, it has been shown to be required 
for the therapeutic actions of SSRIs (Diaz et al., 2012). These find-
ings indicate that the 5-HT2B receptor has important roles both in 
periphery and in the CNS and that it is one of the key mediators 
of 5-HT functions during development. 
In this review we focus on the 5-HT2B receptor with the aim to 
show how the use of a suitable model system, Xenopus laevis, 
allowed to unveil new roles of this receptor thanks to the avail-
ability of sophisticated tools for manipulating embryos and gene 
functions. In particular, this review highlights how such studies 
provided detailed information about the mechanisms of 5-HT2B 
receptor function in two complex morphogenetic processes such 
as craniofacial and ocular development. 
Xenopus as a vertebrate model system for develop-
mental studies
Choosing a suitable animal model system to unveil new roles 
of the serotonin signaling during development is one of the most 
important steps for achieving meaningful results.
Fig. 1. Xenopus laevis as a 
model system to study gene 
function. On the left, the life 
cycle of Xenopus laevis. On the 
right, the gene loss of function 
strategy that specifically blocks 
the translation of a gene of 
interest by microinjecting spe-
cific morpholino oligos in one 
side of the embryo. Antisense 
morpholino is targeted to se-
quences close to the translation 
start site. The injected side is 
visualized by the co-injection 
of a reporter mRNA such as 
LacZ or GFP. Examples of 
chromogenic reaction for beta 
galactosidase (red) and GFP 
(green fluorescence) are shown 
in neural stage embryos. 
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Xenopus is a genus of aquatic frogs, native to southern Africa, 
that are tolerant to starvation, diseases and other insults that make 
them very easy to keep in captivity. Thus Xenopus has become 
a very widely used model organism for a variety of biological and 
biomedical researches. In particular, Xenopus is one of the most 
popular systems used in the field of developmental biology since 
it offers experimental advantages over other widely used model 
systems such as mice. These advantages come from the large 
number, accessibility and large size of the eggs, which can be 
easily fertilized in vitro producing huge numbers of synchronized 
embryos that can be observed developing from the first cell division 
to a tadpole in about 36 hours (Fig. 1). The embryos can be easily 
manipulated, injected, grafted or labeled. In particular, researchers 
can easily manipulate gene functions in large numbers of embryos 
by using morpholino-modified antisense oligos and by mRNA 
mis-expression. This can be performed by injecting morpholinos 
or in vitro transcribed mRNAs into one cell of the two-cell stage 
embryos. This procedure provides a useful internal control, as the 
first cleavage results in gene down or up-regulation in only one side 
of the embryo (Fig. 1). In addition, the availability of a well-defined 
fate map of each blastomere allows addressing the microinjection 
in specific regions of the embryo so that a morpholino-mediated 
conditional knockdown approach can be easily obtained. This ap-
proach can overcome lethal effects and allows studying defects 
that appear in later stages of development. A homotipic transplant 
assay system has also been settled up in Xenopus embryos al-
lowing detecting cell contribution to specific structures as well as 
the cell autonomous or non-autonomous contribution of specific 
gene activity in developmental processes (Borchers et al., 2000; 
Reisoli et al., 2010) (Fig. 2). Xenopus is also successfully used for 
chemical genetics and drug screen studies (Wheeler and Brändli, 
2009). In particular, chemical genetics provides a complementary 
approach to loss or gain of function mutations in the study of 
complex biological processes.
Public databases harbor the nucleotide se-
quences of almost 2 million expressed sequences 
tag (EST) from both X. laevis and X. tropicalis (the 
diploid sister species of X. laevis, whose genome 
is nearly sequenced) and microarrays are available 
for both species, thus an impressive collection of 
genomic and transcriptomic tools is rapidly becom-
ing available for this model system. 
Xenopus as a tetrapod shares a long evolution-
ary history with mammals: they share similarities 
at the level of the genomes, in organ development, 
anatomy and physiology and therefore it represents 
an excellent model to predict human biology. 
5-HT and 5-HT2B receptor in Xenopus 
development
In Xenopus embryos 5-HT is present as a ma-
ternal pool in the eggs and the main components of 
the serotonergic system are expressed during the 
earliest stages of embryonic development (Fuku-
moto et al., 2005; Nikishin et al., 2012).
In the CNS 5-HT is first produced by serotonergic 
neurons of the raphe nuclei at tailbud stages (van 
Mier et al., 1986). Serotonergic cells are found in 
Fig. 2. Neural crest cell transplantation assay. Top: Scheme of the cranial NCCs transplant 
assay at neurula stage (st. 16). (A,B,C) Lateral views of an early tailbud (stage 28) transplanted 
embryo: (A) bright field; (B) GFP fluorescence in transplanted cranial NCCs; (C) merge.
several other tissues or organs of the Xenopus larvae, such as 
the retina, the skin and the gut (Figs. 3; 4A). A specific population 
of neuroepithelial cells in Xenopus gills has also been shown to 
contain 5-HT (Saltys et al., 2006).
The cloning of the Xenopus 5-HT2B cDNA revealed that the 
predicted protein is conserved among vertebrates, thus substan-
tiating the role of Xenopus as a model system (De Lucchini et 
al., 2003). Two alternative polyadenylation sites were found. The 
same situation was found in the puffer fish Tetraodon, so that a 
functional significance for the use of alternative polyadenylation 
sites, conserved in evolution, may be hypothesized (De Lucchini 
et al., 2001). The genomic organization of the 5-HT2B receptor in 
Xenopus has not been addressed. However, in other organisms 
such as Tetraodon and humans, splice variants and truncated 
forms of the protein have been described (De Lucchini et al., 2001; 
Deraet et al., 2004). It is interesting to note that in some instances 
mutations causing premature truncation of the protein product are 
related to human diseases such as fenfluramine-associated primary 
pulmonary hypertension (Blanpain et al., 2003) or with psychiatric 
diseases (Bevilacqua et al., 2010). 
In Xenopus the 5-HT2B mRNA expression has been detected 
in the post-hatching stages in proliferating regions of the CNS and 
retina, in cranial NCCs and in periocular mesenchyme (POM) (De 
Lucchini et al., 2003; Reisoli et al., 2008; Reisoli et al., 2010).
Pharmacological treatments with the 5-HT2B antagonist ritan-
serin resulted in developmental defects strongly indicating that 
this receptor has a role in Xenopus embryogenesis. Morphological 
alterations included reduced pigmentation and heart defects with 
reduced heartbeats and pericardial edema. Similar heart defects 
have been found in ritanserin-treated mouse embryos (Choi et al., 
1997). Ritanserin-treated Xenopus embryos also revealed ocular 
defects characterized by small and dorsalized eyes with a protrud-
ing lens, delay in the closure of the optic fissure (coloboma) and 
disorganized retinal cytoarchitecture (De Lucchini et al., 2005).
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Role of 5-HT2B signaling in retinal layering and ocular 
morphogenesis
The vertebrate retina is a powerful model to study how the 
nervous system is built up. Progenitor cells proliferate to generate 
six types of neurons and one type of glia, arranged into distinct 
layers. A number of molecules, including transcription factors and 
cell surface receptors, are involved in cell fate determination of 
retinal cell types (cf. Andreazzoli, 2009 for a review). In addition, 
both cell-intrinsic and -extrinsic cues must control the laminar 
organization of the retina. Recent evidence demonstrated that a 
wide range of neurotransmitters and their receptors are present 
during early stage of vertebrate retina development and it has 
been suggested that neurotransmitters may be numbered among 
the extracellular signals contributing to the retinal development. A 
precise coordination of retinal progenitor cell proliferation is essential 
for the formation of a functionally mature retina. Deregulated cell 
proliferation may in fact lead to dysplasia, retinal degeneration or 
retinoblastoma. There is now growing evidence that neurotrans-
mitter systems modulate the proliferation and differentiation of 
retinal progenitor cells. The purinergic and muscarinic systems, for 
example, may take part in the control of retinoblasts proliferation 
while GABA, glutamate and dopamine appear to be involved in 
cell cycle exit and possibly in cell differentiation (for a review see 
Martins and Pearson, 2008). 5-HT was predicted to be among the 
important players, as it is both produced and accumulated in the 
developing retina (Figs. 3; 4A). Moreover, studies carried out in 
mammals and in Xenopus demonstrated that the retina receives 
serotonergic afferents directly from serotonergic neurons located 
in the dorsal raphe nuclei denoted as serotonergic retinopetal 
projections (Gastinger et al., 2006).
In Xenopus retina 5-HT accumulating amacrine cells are found 
starting from tailbud stage 35/36, a time when retinal stratification 
is underway, but before the elaboration of either of the plexiform 
layers (Frederick et al., 1989; Huang and Moody, 1997). Different 
populations of 5-HT-immunoreactive amacrine and bipolar cells are 
found in the inner nuclear layer (INL) and in the gaglion cell layer 
(GCL) (displaced amacrine cells), but only a subtype of amacrine 
cells actually synthesizes 5-HT. Interestingly, the total number of 
5-HT-immunoreactive cells steadily increases through the early 
tadpole stages, peaks at stage 44 and then decreases, whereas 
the number of 5-HT-synthesizing cells continually increases with 
age (14-fold, from 57 to 774 in adult). This fluctuation is due to a 
transient population of amacrine cells that accumulate 5-HT but 
do not synthesize it (Zhu and Straznicky, 1992; Huang and Moody, 
1997). The changes in cell number parallel the changes in absolute 
amount of 5-HT measured in the retina at different developmental 
stages (Frederick et al., 1989). This may suggest that changes 
in 5-HT homeostasis at specific developmental periods influence 
retinal morphogenesis. Photoreceptor cells have also been reported 
to synthesize 5-HT, providing a supply of the substrate needed for 
the production of melatonin, in both mammals and amphibia (Zhu 
et al., 1992; Green et al., 1995).
Different 5-HT receptors are expressed in the retina of mammals 
including humans (Sharif and Senchyna, 2006). In Xenopus at 
least three 5-HT receptor mRNAs, coding for 5-HT1A, 5-HT2B and 
5-HT2C respectively, are expressed in the larval retina (Marracci 
et al., 1997; De Lucchini et al., 2003). Pharmacological evidence, 
coupled with the 5-HT2B receptor spatio-temporal gene expres-
sion pattern, suggested that this receptor could be the candidate 
mediator of the 5-HT action on retinal development. The most 
prominent 5-HT2B mRNA expression in the retina was found in 
the tadpole ciliary marginal zone (CMZ), which is the source of 
retinal stem cells during the amphibian larval and adult life. 5-HT2B 
mRNA was also localized in differentiated retinal cells mainly in 
the INL and GCL (De Lucchini et al., 2003).
Loss of function experiments using morpholinos targeting the 
5-HT2B mRNA resulted in loss of the characteristic retinal laminar 
Fig. 3. Visualization of serotonergic cells during Xenopus embryogenesis. Distribution of 
serotonergic cells in Xenopus larvae, as detected in cryostat sections by immunostaining with 
an anti-serotonin antibody. Left panel, upper row: sagittal section of a late tailbud (stage 35) larva 
showing serotonin cells in the raphe nuclei (arrow); middle row, from left to right: serotonergic 
cells are found in the retina (amacrine cells), in the raphe nuclei, and in the skin of a late tailbud 
(stage 42) larva. Right panel: coronal section showing serotonin cells detected in the gut of a 
stage 49 tadpole (red fluorescence). Coronal planes are indicated as a, b, c.
cytoarchitecture (Fig. 4). These morphological 
defects reproduced those observed after ritan-
serin treatment. The altered retinal morphology 
was not due to deregulation of gene expres-
sion of specific cell differentiation markers, as 
markers for retinal cell layers are expressed in 
5-HT2B morphants. Both ritanserin and 5-HT2B 
morpholino treatments increased the number of 
apoptotic cells in Xenopus retina (De Lucchini 
et al., 2005). 
The upregulation of the 5-HT2B receptor 
activity did not affect retinoblast fate choice and 
terminal differentiation since all the main retinal 
cell subtypes were present in 5-HT overexpress-
ing embryos, although they may be displaced 
outside their proper position and layer and 
rosette-like structures may form. Despite the se-
vere alteration in layering, 5-HT2B up-regulated 
retinas did not show increase in apoptotic rate 
suggesting that 5-HT2B receptor may function in 
modulating retinoblast proliferation and survival 
(Reisoli et al., 2008).
Further support to these findings came from 
in vitro studies showing that the 5-HT2B overex-
pression was found per se sufficient to promote 
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cell proliferation in a neuroblastoma cell line (Reisoli et al., 2008). 
These observations are in line with reports demonstrating that 5-HT, 
via 5-HT2B receptor, is an important regulator of cardiac myocyte 
proliferation and survival during mouse development (Nebigil and 
Maroteaux, 2001; Nebigil et al., 2003).
The analysis of clones derived from lipofected retinoblasts 
constitutively expressing 5-HT2B showed a significant increase in 
the percentage of ganglion cells. Ganglion cells are very sensitive 
to cell death regulation and are specifically targeted by survival 
factors: 5-HT may be counted among these factors (De Lucchini 
et al., 2005).
On the whole, the comparison between 5-HT2B gene loss and 
gain of function experiments points out that serotonin signaling via 
5-HT2B receptor is essential for the frog mature retina functionality 
allowing the completion of the retinal layering process by support-
ing retinoblast proliferation and survival but it is not a determinant 
for specific retinoblasts differentiation.
Pharmacological and functional in vivo studies revealed another 
interesting aspect of the 5-HT2B function in ocular development. 
The altered orientation, position and conformation of the eye in the 
larval head cannot be directly explained by mechanisms involved 
in retinal histogenesis. Other ocular defects observed in 5-HT2B 
deregulated embryos are a shorter optic nerve and a failure of the 
choroid fissure closure or coloboma (Fig. 4). A detailed analysis 
of the 5-HT2B mRNA expression pattern revealed its presence in 
the POM, a population of mesenchymal cells derived from both 
the mesoderm and cranial NCCs that surrounds the developing 
eye (Reisoli et al., 2008). POM is known to provide multiple cell 
lineages necessary for normal ocular development as well as 
essential signals for the patterning of ocular primordia including 
the morphogenetic extension of the optic stalk, the anterior eye 
segment development and the optic fissure closure (Gage et al., 
2005). Additional studies are required to unveil the role of 5-HT2B 
signaling in POM development.
5-HT2B signaling and craniofacial morphogenesis/jaw 
joint formation: implications in human birth defects
The fact that 5-HT may play a role in mouse craniofacial mor-
phogenesis was known from time, and malformations caused by 
exposure of cultured mouse embryos to selective 5-HT re-uptake 
inhibitors, such as fluoxetine (SSRI, Prozac) and 5-HT receptor 
antagonists were reported (Shuey et al., 1992; Moiseiwitsch, 
2000). Craniofacial morphogenesis is a complex developmental 
process requiring multiple and coordinated embryological events. 
The visceral skeleton of all jawed vertebrate embryos is organized 
into a rostrocaudal bilateral series of pharyngeal arches that are 
colonized by cranial NCCs, migrating along precise pathways 
from the mid-hindbrain segments of the neural tube. The NCC 
components of the branchial arches give rise to different skeletal 
elements that undergo profound changes during evolution (Sauka-
Spengler and Bronner-Fraser, 2008). In addition, signals from the 
endoderm and the ectoderm, which overlie the branchial arches, 
are crucial for correct craniofacial development and in particular for 
the specification of the first branchial arch (reviewed in Minoux and 
Rijli, 2010). Defining the network that orchestrates such a complex 
series of events is critically important as developmental mistakes 
may occur, leading to NCC-related developmental defects, such 
as craniofacial abnormalities, which account for one-third of all 
congenital human birth defects.
5-HT2B mRNA is present in the branchial arches of late tailbud 
Xenopus embryos, as well as in the branchial arches of the mouse 
embryo at ~E9 (Choi et al., 1997; Lauder et al., 2000; Reisoli et 
al., 2010). However, developmental craniofacial defects in 5-HT2B 
knockout mouse embryos have not been reported, probably because 
the most penetrating phenotype of 5-HT2B mutant mice leads to 
early embryonic death in utero (Nebigil et al., 2000). A possible 
role of the 5-HT2B signaling in craniofacial morphogenesis was 
suspected due to the potent teratogenic activity of its antagonists 
in cultured mouse embryos (Choi et al., 1997; Bhasin et al., 2004). 
In spite of this evidence, the precise mechanisms of the 5-HT2B 
function in craniofacial morphogenesis awaited to be defined.
The first hint to a possible 5-HT2B role in the frog craniofacial 
morphogenesis came from overexpression experiments showing a 
craniofacial skeleton alteration. This phenotype was characterized 
by the formation of an ectopic cartilaginous element, by a reduction 
in the quadrate and subocular cartilages and by altered orbitohy-
oideus muscle connectivity. In 5-HT2B overexpressing embryos 
Xbap (also known as Nkx3.2 ), a gene codifing for a trascription 
Fig. 4. Role of serotonergic signaling during eye development. (A) Se-
rotonergic amacrine cells in Xenopus stage 42 retina (red immunostaining). 
(B-E) Effects of 5-HT2B morpholino injection on Xenopus eye development. 
Lateral (B,C) views of control and injected side of the same tadpole (st. 
42). The arrow in (C) points to the optic fissure that fails to close ventrally. 
(D,E) Hoechst nuclear staining (blue) of cryostat eye cross-sections of 
control and morpholino-injected stage 42 tadpole: note the altered retinal 
layering in (E). ONL, outer nuclear layer; INL, inner nuclear layer; IPL, inner 
plexiform layer; GCL, ganglion cell layer; L, lens.
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factor expressed in the precursor cells of the jaw joint region, was 
ectopically expressed, resembling a mirror-image duplication of the 
wild-type Xbap expression. As shown by homotipic trasplant assay, 
the 5-HT2B activity in NCCs was sufficient, in a cell-autonomous 
manner, to generate the ectopic cartilage. More importantly, 5- 
HT2B activity was not only sufficient but also necessary to shape 
the first branchial arch skeletal elements. Knockdown of 5-HT2B 
expression in Xenopus embryos resulted in Xbap downregula-
tion and in a fusion of a hypomorphic quadrate with the Meckel’s 
cartilage into a single element, leading to the loss of the jaw joint 
(Fig. 5 A-B). The 5-HT2B signaling is therefore required to define 
and sustain the Xbap gene expression necessary for the jaw joint 
formation, which is one the major evolutionary novelties of verte-
brates (Reisoli et al., 2010). Another signaling pathway known to be 
able to positively control Bapx1 expression is endothelin 1 (Edn1) 
(Walker et al., 2007). Since both endothelin and 5-HT2B signaling 
act through the PLC beta 3 effector (Raymond et al., 2001), they 
could cooperate in modulating Xbap expression and reinforcing 
the PLC pathway in cranial NCCs during the first arch patterning 
(Reisoli et al., 2010) (Fig. 5C). As the regulatory network involved in 
the specific expression of Bapx1 in vertebrates is conserved (New-
man et al., 1997; Miller et al., 2003; Tucker et al., 2004), it may be 
hypothesized that 5-HT2B signaling controls Bapx1 expression in 
mammalian embryos as well. This aspect, to be verified and further 
to SSRIs such as persistent pulmonary hypertension, cardiac 
defects and spontaneous abortion (Oberlander et al., 2009; Tuc-
cori et al., 2009; Bellissima et al., 2012). An association between 
congenital heart defects and the use of SSRIs in pregnancy has 
been demonstrated (Sadler, 2011) and these findings are in line 
with animal model studies showing a key role of 5-HT2B receptor 
signaling in heart development (Gaspar et al., 2003). Interest-
ingly, recent investigations demonstrated that 5-HT2B is required 
for serotonin selective antidepressant actions (Diaz et al., 2012) 
and in astrocytes fluoxetin and paroxetine (SSRIs) seem to act as 
subtype-specific agonists for 5-HT2B receptors (Zhang et al., 2010). 
Recently, the occurrence of OAVS, a syndrome characterized by 
abnormal development of facial structures derived from the first 
and second branchial arches, has been reported in an infant born 
to a woman with a history of prenatal fluoxetine treatment through-
out her pregnancy, suggesting an involvement of 5-HT signaling 
also in human craniofacial morphogenesis (Farra et al., 2010). 
Cardiovascular malformations and facial dysmorphism have been 
reported in two twins born to a woman who used paroxetine (SSRI) 
during pregnancy (Marsella et al., 2010). A worldwide prospective 
analysis revealed that the incidence of mood and anxiety disorders 
is destined to progressively grow in the population so that a more 
extensive prescription of the SSRIs is expected to occur. This led 
to consecutive alerts by the U.S. Food and Drug Administration in 
Fig. 5. Role of serotonergic signaling in the first branchial arch development. (A,B) 
Craniofacial skeletal alterations in 5-HT2B morphants (st. 49). Alcian blue staining of a 
flat mount embryo showing the jaw joint region of the control (A) and injected (B) side. 
The jaw joint (black arrow in the control side) is lacking in the injected side; note also 
the reduction of the quadrate (Q) and the absence of the ventral cartilaginous muscular 
process of the Meckel’s cartilage, which is present in the control side (red arrow). Q, 
quadrate; M, Meckel’s cartilage. (C) Scheme of the role of the 5HT-2B receptor signaling 
in patterning the dorso-ventral axis of the first branchial arch. The scheme is based on 
the experimental data reported in Reisoli et al., 2010. 5-HT2B receptor signaling is both 
sufficient and necessary to induce and maintain Xbap (Nkx2.2) gene expression in the 
medial region of first branchial arch giving rise to the jaw joint, possibly cooperating with 
endothelin receptor signaling.
explored, could be of interest particularly in the light 
of the possible involvement of BAPX1 in human birth 
defects, such as the oculo-articular-vertebral spectrum 
(OAVS), which exhibits alterations in the first and sec-
ond branchial arch derivatives (Fischer et al., 2006).
In conclusion the data obtained in the experimental 
model Xenopus revealed that the 5-HT2B signaling 
can be included into the complex interactive network 
of extrinsic factors that regulates craniofacial skeleton 
development in vertebrates. 
Concluding remarks
Work in a suitable vertebrate model system such as 
Xenopus embryos revealed novel roles of the 5-HT/5-
HT2B signaling in eye and craniofacial morphogenesis. 
These findings are not only relevant in terms of evo-
lutionary biology but may have consequence in our 
understanding of congenital defects, including human 
birth abnormalities. 
The role of 5-HT2B receptors in ocular and facial 
morphogenesis is consistent with their expression 
in cranial NCCs, a transient population of migratory 
embryonic multipotent cells that arises from neural 
ectoderm and populates the pharyngeal arches. Dis-
ruption of cranial NCCs development lead to human 
congenital craniofacial and ocular defects that are 
included among the so called “neurocristopathies”. 
Although these disorders are generally associated to 
genetic abnormalities, they can also be induced by 
prenatal exposure to teratogens. SSRIs represent a 
class of commonly used antidepressants in pregnant 
and lactating women and several epidemiological in-
vestigations report long-lasting molecular, physiological 
and behavioral changes in offspring prenatally exposed 
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2005 and 2006, stating that the use of SSRIs in pregnancy was 
associated with increased birth defects (Chambers et al., 2006, 
Wogelius et al., 2006). Prenatal exposure to SSRIs also impacts 
fetal brain development that may have long-term mental health 
implications (Hanley et al., 2013). The mode of action of SSRIs 
suggests the involvement of complicated downstream mechanisms, 
including long-term changes in gene expression and neuroplasticity. 
Experimental studies in rodents have in fact shown that administra-
tion of SSRIs during a key developmental window creates changes 
in brain circuitry and maladaptive behavior, such as increased 
anxiety in adulthood (Ansorge et al., 2008). On the whole, these 
discoveries have significant implications for the prescription of 
antidepressants to pregnant women and should stimulate further 
animal models and human research efforts.
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